Curing Hepatitis C in Primary Care: Developing a sustainable HIV, viral hepatitis, and sexual health workforce
Wed 29th May @ 6:00 pm
As a GP, you can play a critical role in diagnosing and treating hepatitis C. In the Northern Sydney PHN, there are 3,823 people living with CHC. Treatment uptake is currently at 25.9%. Oral direct-acting antivirals (DAAs) offer cure rates greater than 95% with shorter therapy duration and reduced toxicity. One in five Australians living with chronic HCV do not know their status. Additionally, around 170,000 eligible Australians could be missing out on treatment. General practitioners (GPs) can prescribe DAAs on the General Schedule.
This update will focus on case finding, testing, patient assessment and treatment of hepatitis C infection in primary care settings.